Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Generic Priority Review Expanded In Senate User Fee Bill

May 12 2017

• By Derrick Gingery

priority button

Related Content

Drug Importation Blocked But Not Forgotten As User Fee Bill Clears Senate Cmte

May 12 2017

Expanded Access Amendment Could Blunt 'Right To Try' Legislation In US

May 12 2017

User Fee Bill Caught In Comey Firing Tidal Wave

May 11 2017

User Fee Add-Ons: Senate Bill Tweaks Orphans, Opioids, Patient Data

May 09 2017

Drug Pricing Bill May Make Six-Month ANDA Review Slower Than Eight-Month Review

Feb 03 2017

GDUFA II: Priority Reviews Considered For Some ANDAs

Nov 06 2015

Generic Drug First-Cycle Approval Rates Lagging Under GDUFA I

Oct 26 2016

ANDAs Can Get Priority, Eight-Month Reviews Under User Fee Deal

Sep 24 2016

Complex ANDAs To Be Allowed Pre-Submission Product Meetings

Oct 24 2016

Additional Topics

United States Review Pathway Generic Drugs Regulation FDA Legislation BioPharmaceutical

More from Review Pathways

More from Pathways & Standards

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window